Ginkgo Bioworks -CW27DNABWPreferred / convertible
13F holders, Q3 2025 (September 30)1holders −1
0new positions
1sold out
$0.01avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Ginkgo Bioworks -CW27 (DNABW) in their 13F filings, down 1 from Q2 2025. 0 opened new positions and 1 sold out. The largest holder was Harbor Investment Advisory, LLC ($1).
- Company
- Ginkgo Bioworks -CW27
- CUSIP
- 37611X118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $1 |
All 13F filers, Q2 2025 → Q3 2025: 60 shares sold, net −60 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Harbor Investment Advisory, LLC | — | No change | 140 | $1 |
"% of holder's portfolio" is DNABW's weight in each manager's 13F, not the share of Ginkgo Bioworks -CW27 the manager owns.